The Food and Drug Administration is planning to approve Moderna and Pfizer’s COVID-19 vaccines for emergency use as quickly as possible, according to U.S. Department of Health and Human Services’ Alex Azar. (CNBC)
Data from Moderna’s coronavirus vaccine late-stage trial shows the vaccine is 94.5% effective. Pfizer has already reported that its vaccine is more than 90% effective. Moderna’s vaccine is expected to be easier to distribute as it can be stored in normal fridge temperatures, unlike Pfizer’s vaccine. (Reuters)
Sixty-five employees at the World Health Organization in Geneva have contracted the virus, according to an internal memo. Half of those infected were working from home. The agency is investigating whether transmission for the others occurred in the headquarters. (Associated Press)
There were more than one million new coronavirus cases in the U.S. last week. The death rate increased by 12% with more than 1,100 deaths each day. (Reuters)
The third annual MM+M Holiday Contest is underway. Submit your entry by December 7 to be part of the voting period. (MM+M)
